Latest news

03-Sep-2010
Novartis and collaborators discover novel antimalarial drug candidate

30-Aug-2010
Novartis International BioCamp provides forum for future research and business leaders to engage in scientific innovation

27-Aug-2010
Novartis drug Tasigna® approved in Switzerland after fast-track review for treatment of patients with newly diagnosed Ph+ CML

View all press releases

 

 

Stay connected

Sign up for email alerts

Learn more about RSS feeds and how to subscribe

English newsfeed

German newsfeed

French newsfeed

Follow Novartis on Twitter